Recombinetics Workshop: From pigs to patients – gene editing technologies for lifesaving human therapeutics

Founded in 2008, Recombinetics applies precision genetics to improve human and animal health.  The company develops customized biomedical swine models that replicate human diseases for preclinical research.   RCI is also partnering with world-class medical institutions to develop human cells, tissues and organ products in a pig for transplantation back to humans.